Back to Search
Start Over
Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors
- Source :
- OncoImmunology, Vol 7, Iss 12 (2018), OncoImmunology, OncoImmunology, Taylor & Francis, 2018, 7 (12), pp.e1503032. ⟨10.1080/2162402X.2018.1503032⟩, OncoImmunology, 2018, 7 (12), pp.e1503032. ⟨10.1080/2162402X.2018.1503032⟩
- Publication Year :
- 2018
-
Abstract
- International audience; Oncolytic viruses selectively target and kill cancer cells in an immunogenic fashion, thus supporting the establishment of therapeutically relevant tumor-specific immune responses. In 2015, the US Food and Drug Administration (FDA) approved the oncolytic herpes simplex virus T-VEC for use in advanced melanoma patients. Since then, a plethora of trials has been initiated to assess the safety and efficacy of multiple oncolytic viruses in patients affected with various malignancies. Here, we summarize recent preclinical and clinical progress in the field of oncolytic virotherapy.
- Subjects :
- 0301 basic medicine
lcsh:Immunologic diseases. Allergy
cavatak
medicine.medical_treatment
Immunology
[SDV.CAN]Life Sciences [q-bio]/Cancer
Review
medicine.disease_cause
lcsh:RC254-282
Food and drug administration
03 medical and health sciences
maraba mg1
mv-nis
0302 clinical medicine
Immune system
pexa-vec
[SDV.CAN] Life Sciences [q-bio]/Cancer
medicine
Immunology and Allergy
In patient
Advanced melanoma
dnx-2401
business.industry
hf10
Immunotherapy
[SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
3. Good health
Oncolytic virus
030104 developmental biology
Herpes simplex virus
Pexa- Vec
Oncology
030220 oncology & carcinogenesis
t-vec
Cancer cell
Cancer research
reolysin
[SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy
business
lcsh:RC581-607
Subjects
Details
- ISSN :
- 21624011 and 2162402X
- Volume :
- 7
- Issue :
- 12
- Database :
- OpenAIRE
- Journal :
- Oncoimmunology
- Accession number :
- edsair.doi.dedup.....d0b133a34ea7712a3bc2350efba6f2ac